Comparing Amplifon (AMFPF) & Its Rivals

Amplifon (OTCMKTS:AMFPF) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare Amplifon to similar companies based on the strength of its risk, institutional ownership, analyst recommendations, earnings, dividends, profitability and valuation.

Profitability

This table compares Amplifon and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Amplifon	3.12%	14.94%	4.42%
Amplifon Competitors	-7.86%	-135.41%	-1.59%

Valuation and Earnings

This table compares Amplifon and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Amplifon	$2.71 billion	$103.33 million	36.88
Amplifon Competitors	$21.44 billion	$301.67 million	-1.73

Amplifon’s competitors have higher revenue and earnings than Amplifon. Amplifon is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

Amplifon has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, Amplifon’s competitors have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Amplifon and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amplifon	1	1	2	0	2.25
Amplifon Competitors	1877	7751	13384	833	2.55

As a group, “Healthcare Providers & Services” companies have a potential upside of 13.47%. Given Amplifon’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Amplifon has less favorable growth aspects than its competitors.

Institutional and Insider Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Amplifon competitors beat Amplifon on 9 of the 13 factors compared.

About Amplifon

Amplifon is an Italian hearing-care company founded in Milan in 1950. It provides hearing solutions through a network of retail locations and other customer-service channels. The company offers hearing assessments, advice on hearing aids, device fitting and personalization, and ongoing support. Its products and services also include hearing-aid accessories and maintenance. Amplifon serves customers across Europe, the Americas and the Asia-Pacific region. Its operations include the Amplifon brand and other local hearing-care businesses.